🇺🇸 FDA
Patent

US 8168751

Interferon alpha mutant and its polyethylene glycol derivative

granted A61KA61K38/00A61K47/60

Quick answer

US patent 8168751 (Interferon alpha mutant and its polyethylene glycol derivative) held by Beijing Tri-Prime Genetic Engineering Co., Ltd expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beijing Tri-Prime Genetic Engineering Co., Ltd
Grant date
Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K47/60, A61P, A61P31/12